Michael Halpin

Chief Operating Officer bei VERICEL CORPORATION

Vermögen: 49 367 $ am 31.03.2024

62 Jahre

Health Technology

Consumer Services

Aktive Positionen von Michael Halpin

Unternehmen	Position	Beginn	Ende
VERICEL CORPORATION	Chief Operating Officer	15.06.2019	-
VERICEL CORPORATION	General Counsel	10.04.2017	15.06.2019

Unternehmen	Position	Beginn	Ende
Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	General Counsel	01.02.2002	-
	Corporate Officer/Principal	-	01.04.2017
Sanofi Corp.	Corporate Officer/Principal	-	-

University of Virginia

Graduate Degree

International

Vereinigte Staaten

Operativ

General Counsel	2
Corporate Officer/Principal	2
Chief Operating Officer	1

Sektoral

Health Technology	3
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
VERICEL CORPORATION	Health Technology

Private Unternehmen	2
Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	Health Technology
Sanofi Corp.